Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 277 of 6351
-
Can a community health worker program save lives in advanced HIV?
Disease control Not yet recruitingAdults who are hospitalized in Lusaka, Zambia, and found to have advanced HIV disease will be enrolled and randomly assigned to receive the ARC intervention or standard of care. All participants will then be followed through the end of the hospitalization and for up to 1 year aft…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a single dose of valproic acid help heal the brain after injury?
Disease control Not yet recruitingThe long-term goal of the clinical trial is to develop effective, safe, and easily administered life-saving treatments for patients with moderate to severe traumatic brain injury (TBI). Patients with moderate to severe TBI will randomly receive either: 1. Standard of care treat…
Phase 2/3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a daily pill calm severe eczema from the inside?
Disease control Not yet recruitingTo evaluate the efficacy and safety of oral administration of dose-dependent EC-18 for 16 weeks in patients with moderate to severe atopic dermatitis
Phase 2 • Sponsor: Enzychem Lifesciences Corporation • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug combo aims to improve islet transplants for diabetics with kidney disease
Disease control Recruiting nowSingle arm- subject treated with Tegoprubart and everolimus. The purpose of this research is to gather information on the safety and effectiveness of investigational regimen containing 2 experimental components: * An investigational drug called Tegoprubart and * Human pancreati…
Phase 1/2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New hope for rare blood cancer: QUANTUM trial tests targeted therapy after transplant
Disease control Recruiting nowThis phase II trial compares standard consolidation with daratumumab, carfilzomib, lenalidomide, and dexamethasone to consolidation with teclistamab following standard induction therapy and autologous hematopoietic stem cell transplant for improving overall survival of patients w…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could less be more? new trial shortens leukemia drug course for seniors
Disease control Recruiting nowThis phase II MyeloMATCH treatment trial compares ASTX727 with standard duration versus shorter duration of venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML). ASTX727 is a combination of decitabine and cedazuridine. Decitabine is in a class of medicatio…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a simple blood thinner save teens from deadly clots?
Prevention Not yet recruitingCritically ill adolescents are at greatest risk for developing hospital-acquired venous thromboembolism. To date, no phase 3 randomized controlled trials have been conducted for pharmacological thromboprophylaxis as primary venous thromboembolism prevention in children. The inves…
Phase 3 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
New Two-Drug combo aims to beat back returning myeloma
Disease control Recruiting nowThis phase Ib/II trial compares the effect of teclistamab and pomalidomide to standard treatment with carfilzomib, pomalidomide and dexamethasone in treating patients with multiple myeloma that has come back after a period of improvement (relapsed). Teclistamab is a bispecific an…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a phone app help young adults with HIV stay on track?
Disease control Not yet recruitingThe goal of this interventional clinical trial is to test an an app, PL4Y, installed on a mobile smartphone to see if it can help participants aged 18-29 years who have HIV achieve success with their HIV care and feel supported by their clinic community. The first 6 months will …
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug combo takes on rare, Drug-Resistant lung bug
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a new combination antibiotic treatment (Arm D) works to treat a rare lung condition called mycobacterium abscessus pulmonary disease in people of any age and sex, when compared to the standard treatments. It will also learn about the…
Phase 2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a silent word ease both PTSD and chronic pain? a VA trial puts mantram repetition to the test
Symptom relief Not yet recruitingApproximately 450,000 Veterans Health Administration service users have both posttraumatic stress disorder (PTSD) and chronic pain (CP); treatments that efficiently target both PTSD and CP are limited, and new interventions should address the unique needs of Veterans with PTSD/CP…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a simple topical treatment stop a common Post-Surgery complication in ulcerative colitis?
Prevention Not yet recruitingUlcerative colitis (UC) is a chronic intestinal disease, often debuting early in life, and affecting the colon and rectum. The therapy is mainly medical and based on 5-aminosalicylic acid (5-ASA) and steroids. The last 20 years numerous new advanced therapies have become availabl…
Phase 4 • Sponsor: University Hospital, Linkoeping • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Could an immunotherapy drug keep early lung cancer from returning?
Disease control Recruiting nowThis phase III trial compares the effect of atezolizumab (or atezolizumab and recombinant human hyaluronidase) to standard observation for preventing cancer return after surgery (recurrence) in patients who have undergone a complete surgical removal (resection) of stage I non-sma…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Nature escapes in a headset: a new way to calm cancer infusions?
Symptom relief Not yet recruitingThe goal of this randomized clinical trial is to determine whether immersive virtual reality (VR), delivered during scheduled immunotherapy or chemo-immunotherapy infusions, can reduce state anxiety in patients with lung cancer compared with standard care. The main question this…
Sponsor: Dott.Claudio Sini • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a hormone mimic curb the need for bloodletting in a blood cancer?
Disease control Not yet recruitingPolycythemia vera (PV) is a long-term condition in which the bone marrow makes too many red blood cells (RBCs). Bone marrow is the soft tissue inside the large bones where blood cells are made. When there are too many RBCs, called erythrocytosis, the blood can become thicker and …
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a phone app ease suicidal thoughts in young adults?
Symptom relief Not yet recruitingThis study will evaluate the effectiveness of MindBridge, a dialectical behavior therapy (DBT)-informed mobile health module delivered through a WeChat mini-program, among Chinese young adults aged 18 to 24 years with mild-to-moderate suicide risk. In the randomized controlled tr…
Sponsor: Jiangsu Medical College • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New Two-Step surgery could spare High-Risk women from early menopause
Prevention Not yet recruiting• FIMBRIMENOP-2402 study aims to evaluate the long-term management of cancer risks in premenopausal women who have a genetic predisposition to tubo-ovarian or primary peritoneal carcinoma, such as mutations in BRCA1, BRCA2, RAD51C, RAD51D, or PALB2 genes. This study offers an alt…
Sponsor: Centre Oscar Lambret • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Could a pill plus walking ease knee pain and lift mood in veterans?
Symptom relief Not yet recruitingKnee osteoarthritis (KOA) is one of the most common causes of chronic pain, mobility problems, and disability among United States Veterans. Many Veterans with KOA also experience depressive symptoms, which can worsen pain, reduce motivation to exercise, and make recovery more dif…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a wearable sensor improve blood sugar control in hospitals?
Disease control Not yet recruitingTitle: Continuous glucose monitoring vs point of care glucose measurements for in-hospital type 2 diabetes management - STENO In-Hospital CGM Trial - a multisite, randomized controlled trial. Aim To investigate the effects and feasibility of continuous glucose monitoring (CGM) o…
Sponsor: Steno Diabetes Center Copenhagen • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Experimental cell therapy takes on Drug-Resistant melanoma
Disease control Not yet recruitingThe protocol is a Simon's 2-stage, non-randomized, open label, multi-site, phase 2 trial for patients with advanced metastatic, recurrent and unresectable malignant melanoma that has recurred or relapsed after prior anti-PD-(L)1 therapy.
Phase 2 • Sponsor: Rapa Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC